Fremanezumab Recruiting Phase 4 Trials for Migraine Supportive Care

IndicationsStatusPurposePhase
RecruitingSupportive Care4
clinicaltrials.gov IdentifierTitleDrugs
NCT04461795Efficacy of AJOVY (Fremanezumab-vfrm) on Interictal Migraine Related Burden